CARDIOMETABOLIC HEALTH CONGRESS
Interventional Cardiology
CME/CE Activities
News Digest
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
Cardiometabolic Health Congress Hosts 2023 Women’s Masterclass in California
Abstracts Published from the 17th Annual Cardiometabolic Health Congress
2022 FDA-Approved Cardiometabolic Drugs and Devices
Aortic Stenosis: Updated Guidelines for Diagnosis and Management
CardioMEMS Shows Promise for Expanded Use Despite Falling Short in Trial
Interventional Cardiology: The Latest Specialty InsightsÂ
post
Cardiometabolic Disease
post
Cardiometabolic Disease
post
Cardiometabolic Disease
post
Cardiovascular Disease
post
Interventional Cardiology
Expert Highlights and Perspectives
Dr. Angela Lowenstern, Assistant Professor of Medicine at Vanderbilt University Medical Center speaks on the evolving role of TAVR at the 2024 Women’s Health & Wellness Masterclass meeting on April 20, 2024. To download a copy of the slides, please click here.
Resources
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association
2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation